“An experiment in faith”

The second president of Radcliffe, Le Baron Briggs, described Radcliffe as “an experiment in faith.”… From the very beginning...

Return to main article:

The second president of Radcliffe, Le Baron Briggs, described Radcliffe as “an experiment in faith.”…

From the very beginning of Elizabeth Cary Agassiz’s inspiration, to the vision of Mary Ingraham Bunting…to the foresight of Neil Rudenstine, Radcliffe has always represented a commitment of faith—to intellectual excellence and to the principle of opening access to higher education to all who are talented enough to benefit from it.

I owe an enormous debt to all of them, and I owe an enormous debt to all of you. My commitment to this “experiment in faith” will remain unfaltering. I have loved being Radcliffe’s founding dean, and I thank you all for giving me this opportunity and helping me all along the way. Thank you from the bottom of my heart for this.

~Drew Gilpin Faust, Radcliffe Institute for Advanced Study dean and Harvard University president-elect, at the Radcliffe Day luncheon, June 8

Most popular

“AI Anxiety”

The Undergraduate on the uneasy collision of technology and writing

Harvard Weathers a Year of Turmoil

The federal government has launched unprecedented actions against the University. Here’s a guide.

Trump Administration Will Investigate Alleged Visa Fraud at Harvard

The announcement comes two days after a federal appeals court heard arguments about an international students ban.

Explore More From Current Issue

A smiling elderly man in glasses sits comfortably in a striped armchair.

Plus, veteran higher education leader Thomas Ehrlich reflects on university curricula for his 70th reunion

A woman with long, wavy hair wearing a white suit, seated in a bright, modern room.

The Harvard graduate’s roundtable talk show touches on hot button issues from religion to sex. 

A glowing bulb shape surrounded by colorful, swirling energy lines against a blue background.

Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.